UTMB Research Ethics Consultants


Michele A. Carter, Ph.D., Director, UTMB Institutional Ethics Program and CRC Research Subject Advocate (e-mail)
Toni D'Agostino, B.A., M.A., Director, Office of Sponsored Programs, Office of the Associate Dean for Research Services, UTMB (e-mail)
Evelyn M. (Bernadette) McKinney, J.D., Ph.D., Assistant Professor (e-mail)

The RECS does not merely provide ethical expertise to researchers, but rather is a collaborative venture in which practitioners of science and ethics scholars work together to inform and strengthen core values and best practices in research. Beyond compliance with regulations, the RECS seek to deepen UTMB's commitment to professionalism, trust-building, and to the principles of respect for persons, beneficence and justice. Ethics consultants are available by phone and in-person to provide investigators and their teams in individualized, real-time expertise and problem-solving strategies.

Typical ethical issues arising in the clinical translational environment include:

If you have a doubt, concern, question or any issue at all that you think someone trained in clinical research ethics might be able to help you with, then this service is here for you.

This service to the UTMB research community is supported by a President's Cabinet Award. The consultation service is intended to compliment the work of the Institutional Review Board, which is the authoritative body for reviewing any research involving human subjects at UTMB. The Institutional Review Board is usually called, "the IRB".

All UTMB research that involves human subjects must be approved by the IRB. In deciding if they can approve a research project (the protocol), the IRB follows the rules the U.S. Government has set up to protect people who take part in research. These rules are found in: The Code of Federal Regulations: Title 45, Part 46. For Food and Drug Administration (FDA) regulations, see: The Code of Federal Regulations: Title 21, Part 50.